These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30785699)

  • 1. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
    Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
    Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
    Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
    Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer.
    Joh HK; Giovannucci EL; Bertrand KA; Lim S; Cho E
    J Natl Cancer Inst; 2013 May; 105(10):726-32. PubMed ID: 23568327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on "Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer." Joh HK, Giovannucci EL, Bertrand KA, Lim S, Cho E, Department of Medicine, Seoul National University College of Medicine, Seoul, South Korea. J Natl Cancer Inst 2013; 105(10):726-32. [Epub 2013 Apr 8]. doi: 10.1093/jnci/djt082.
    Boorjian S
    Urol Oncol; 2014 Aug; 32(6):933-4. PubMed ID: 25087670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
    Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
    PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma.
    Xu S; Song J; Zhang ZH; Fu L; Gao L; Xie DD; Yu DX; Xu DX; Sun GP
    Sci Rep; 2019 Nov; 9(1):16719. PubMed ID: 31723229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
    Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
    Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 25-hydroxyvitamin D concentrations and risk of incident cancer in adults with hypertension: A nested case-control study.
    Lin T; Song Y; Zhang X; Guo H; Liu L; Zhou Z; Wang B; Tang G; Liu C; Yang Y; Ling W; Yuan Z; Li J; Zhang Y; Huo Y; Wang X; Zhang H; Qin X; Xu X
    Clin Nutr; 2019 Oct; 38(5):2381-2388. PubMed ID: 30473442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.
    Platz EA; Hankinson SE; Hollis BW; Colditz GA; Hunter DJ; Speizer FE; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1059-65. PubMed ID: 11045788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
    Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
    Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.
    Southard EB; Roff A; Fortugno T; Richie JP; Kaag M; Chinchilli VM; Virtamo J; Albanes D; Weinstein S; Wilson RT
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):191-201. PubMed ID: 22086884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea.
    Shin WK; Kim Z; Youn HJ; Cho J; Lee JE
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29558405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
    Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
    Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
    Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women.
    Liang G; Nan H; Qureshi AA; Han J
    PLoS One; 2012; 7(4):e35211. PubMed ID: 22493740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of Vitamin D Status and Risk of ESRD.
    Rebholz CM; Grams ME; Lutsey PL; Hoofnagle AN; Misialek JR; Inker LA; Levey AS; Selvin E; Hsu CY; Kimmel PL; Vasan RS; Eckfeldt JH; Coresh J;
    Am J Kidney Dis; 2016 Feb; 67(2):235-42. PubMed ID: 26475393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.